Compare SNY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNY | COP |
|---|---|---|
| Founded | 1994 | 1917 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 120.0B |
| IPO Year | N/A | N/A |
| Metric | SNY | COP |
|---|---|---|
| Price | $47.39 | $98.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 18 |
| Target Price | $61.50 | ★ $111.89 |
| AVG Volume (30 Days) | 2.8M | ★ 8.1M |
| Earning Date | 01-29-2026 | 02-05-2026 |
| Dividend Yield | 3.39% | ★ 3.42% |
| EPS Growth | ★ 105.93 | N/A |
| EPS | ★ 8.67 | 7.08 |
| Revenue | $53,890,648,839.00 | ★ $61,280,000,000.00 |
| Revenue This Year | $1.73 | $10.09 |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | ★ $5.44 | $13.90 |
| Revenue Growth | N/A | ★ 7.65 |
| 52 Week Low | $44.62 | $79.88 |
| 52 Week High | $60.12 | $106.20 |
| Indicator | SNY | COP |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 56.51 |
| Support Level | $46.10 | $95.97 |
| Resistance Level | $48.17 | $101.92 |
| Average True Range (ATR) | 0.80 | 2.88 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 51.10 | 57.96 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated LNG production and marketing activities across geographies.